Longo J, Smirnov P, Li Z, Branchard E, van Leeuwen JE, Licht JD, Haibe-Kains B, Andrews DW, Keats JJ, Pugh TJ, Trudel S, Penn LZ. The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma. Leukemia. 2021 Mar;35(3):796-808. doi: 10.1038/s41375-020-0962-2.
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
Dr. David W. Andrews
| Director of Biological Sciences Professor, Department of Biochemistry, Univ. of Toronto Sunnybrook Research Institute, 2075 Bayview Avenue,M7-640, Toronto, ON M4N 3M5 |
|
| Phone: | 416-480-6100, ext. 5120 |
Find David Andrews Lab PlasmidsContact Us
©2007- 2024 Dr. David W. Andrews